Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Mallinckrodt
Boehringer Ingelheim
Colorcon
Baxter

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Baxter Hlthcare Corp Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?

BAXTER HLTHCARE CORP has fifty-two approved drugs.

There are twelve US patents protecting BAXTER HLTHCARE CORP drugs. There are two tentative approvals on BAXTER HLTHCARE CORP drugs.

There is one patent family member on BAXTER HLTHCARE CORP drugs in one country and ninety-six supplementary protection certificates in fourteen countries.

Summary for Baxter Hlthcare Corp
International Patents:1
US Patents:12
Tradenames:64
Ingredients:40
NDAs:52

Drugs and US Patents for Baxter Hlthcare Corp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp FUROSEMIDE furosemide INJECTABLE;INJECTION 202747-001 Jan 27, 2014 AP RX No Yes ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp FOSAPREPITANT DIMEGLUMINE fosaprepitant dimeglumine POWDER;INTRAVENOUS 211860-001 Sep 5, 2019 AP RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp NOURESS cysteine hydrochloride SOLUTION;INTRAVENOUS 212535-001 Dec 13, 2019 DISCN Yes No 10,933,089 ⤷  Sign up for a Free Trial Y ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 091397-003 Aug 8, 2013 AP RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp FLUCONAZOLE IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 077947-001 May 26, 2010 AP RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Baxter Hlthcare Corp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare Corp CLINOLIPID 20% olive oil; soybean oil EMULSION;INTRAVENOUS 204508-001 Oct 3, 2013 5,840,757 ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp TRANSDERM SCOP scopolamine SYSTEM;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 4,031,894 ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 5,213,804 ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp TRANSDERM SCOP scopolamine SYSTEM;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 4,436,741 ⤷  Sign up for a Free Trial
Baxter Hlthcare Corp PRALIDOXIME CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 018799-001 Dec 13, 1982 3,629,425 ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Baxter Hlthcare Corp Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 C300617 Netherlands ⤷  Sign up for a Free Trial PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
2957286 LUC00094 Luxembourg ⤷  Sign up for a Free Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
0302769 SPC/GB98/039 United Kingdom ⤷  Sign up for a Free Trial PRODUCT NAME: PURIFIED SOYABEAN OIL IN COMBINATION WITH PURIFIED OLIVE OIL.; REGISTERED: FR NL 19107 19951128; UK 00116/0313 19980730
1685839 92292 Luxembourg ⤷  Sign up for a Free Trial PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
0430190 SPC/GB05/032 United Kingdom ⤷  Sign up for a Free Trial PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Dow
Harvard Business School
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.